
NosoVeille – Bulletin de veille                               Juillet 2016 
 
    3 / 34 
 
Marschall P; Hübner NO; Maletzki S; Wilke F; Dittmann K; Kramer A. Attitudes and perceptions of health care 
workers in Northeastern Germany about multidrug-resistant organisms. American journal of infection control 
2016/06; 44(6): e91-e94. 
 
Mots-clés : ATTITUDE; PERSONNEL; RESISTANCE; ANTIBIORESISTANCE 
 
There were 256 health care workers  in 39 facilities  who were interviewed  about their perceptions of the 
quality  of  care  of  patients  with  and  without  multidrug-resistant  organisms  based  on  a  standardized 
questionnaire. There are remarkable differences in the responses between facility types (acute care hospitals, 
long-term care hospitals, rehabilitation hospitals, and home care services). Hygiene management must be 
specifically tailored to the requirements of each facility.   
 
NosoBase ID notice : 415723 
Modification  et  évaluation  du  test  Carba  NP  en  utilisant  une  bande  de  papier  pour  une  détection 
simple et rapide d’entérobactéries productrices de carbapénèmes 
 
Srisrattakarn  A;  Lulitanond  A;  Wilailuckana  C;  Charoensri  N;  Wonglakorn  L;  Piyapatthanakul  S;  et  al. 
Modification and evaluation of the Carba NP test by use of paper strip for simple and rapid detection of 
carbapenemase-producing  Enterobacteriaceae.  World journal of microbiology and  biotechnology  2016/07; 
32(7): 8 pages. 
 
Mots-clés :  ENTEROBACTERIE;  ESCHERICHIA COLI;  KLEBSIELLA PNEUMONIAE;  PSEUDOMONAS 
AERUGINOSA;  TECHNIQUE  DE  DIAGNOSTIC;  TEST;  DEPISTAGE;  BETA-LACTAMASE  A  SPECTRE 
ELARGI; PCR; COUT-EFFICACITE; CARBAPENEME; IMIPENEME 
 
Carbapenemase-producing Enterobacteriaceae (CPE) isolates have now emerged worldwide. We therefore 
modified the phenotypic Carba NP test by use of a filter paper strip for easily and rapidly identifying CPE in 
routine  laboratory.  A  collection  of  56  CPE  and  carbapenemase-producing  Pseudomonas spp.  isolates 
(including 28 NDM-1, 11 IMP-14a, 1 IMP-1, 1 IMP-4, 1 IMP-9, 1 IMP-15, 4 VIM-2, 1 VIM-1, 1 IMP-14a with 
VIM-2, 3 OXA-48, 3 OXA-181  and  1 KPC-2 producers) and 41 non-CPE isolates (including 19 ESBL,  7 
pAmpC, 3 AmpC, 9 ESBL with pAmpC and 3 non-ESBL & non-AmpC producers) as confirmed by the PCR 
methods were tested by the paper strip method using pharmaceutical imipenem/cilastatin as a substrate. 
Bacterial colonies of each isolate were applied directly on filter paper strips dropped with either imipenem-
phenol red (test strip) or phenol red solution alone (control strip). The reaction was read within 5 min. This test 
failed  to  detect  3  OXA-181,  2  OXA-48  and  3  IMP-14a  producers  (85.7%  sensitivity),  whereas  no  false 
positives  were  seen (100%  specificity). Further  evaluation of  the  paper strip  test  in  267  CPE screening-
positive isolates from three hospitals by their medical technologists showed 92.0% sensitivity (100% for NDM 
producers) and 100% specificity compared with the PCR methods. Because of its ease, rapidness and cost 
effective, the paper strip test has a potential for routine CPE testing in low-resource laboratories particularly in 
areas  with  high  prevalence  of  NDM  enzymes,  leading  to  appropriate  antimicrobial  therapy  and  infection 
control strategy. 
 
 
Antibiotique 
 
NosoBase ID notice : 415800 
Préserver l’efficacité des antibiotiques, limiter l’émergence des bactéries multirésistantes 
 
Fascia P; Cauterman M; Giard M; Dumartin C; Savey A; Gauzit R. Préserver  l’efficacité des  antibiotiques, 
limiter l’émergence des bactéries multirésistantes. Bulletin CClin-Arlin 2016/06; 3: 1-3. 
 
Mots-clés : ANTIBIOTIQUE; INFORMATION; MULTIRESISTANCE 
 
Dans  le  cadre  du  Plan  d’alerte  sur  les  antibiotiques  2011-2016,  un  collectif  regroupant  une  fédération 
hospitalière  (la  Fédération  Hospitalière  de  France),  une  société  savante  (la  SPILF)  et  une  association 
d’usagers (Le Lien) a initié une campagne sur le juste usage des antibiotiques. Cette campagne s’intitule «les 
antibios… juste ce qu’il faut» et elle s’inscrit dans un partenariat avec l’Alliance contre le développement des 
bactéries multirésistantes (AC2BMR).  
Cette  campagne  repose  sur  un  engagement  des  établissements  de  santé  et  un  engagement  individuel 
nominatif  des  prescripteurs.  Ces  engagements,  rendus  publics  par  affichage,  ont  pour  objectif  principal 
d’améliorer l’usage des antibiotiques.